0000899243-18-027509.txt : 20181026 0000899243-18-027509.hdr.sgml : 20181026 20181026092934 ACCESSION NUMBER: 0000899243-18-027509 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181023 FILED AS OF DATE: 20181026 DATE AS OF CHANGE: 20181026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arix Bioscience plc CENTRAL INDEX KEY: 0001700449 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 181140528 BUSINESS ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J 6EQ BUSINESS PHONE: 44(0)20 7290 1050 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J 6EQ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arix Bioscience Holdings Ltd CENTRAL INDEX KEY: 0001756884 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 181140529 BUSINESS ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J6EQ BUSINESS PHONE: 44(0)20 7290 1050 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J6EQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 61(0)428-338-594 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-23 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001700449 Arix Bioscience plc 20 BERKELEY SQUARE MAYFAIR, LONDON X0 W1J 6EQ UNITED KINGDOM 0 0 1 0 0001756884 Arix Bioscience Holdings Ltd 20 BERKLEY SQUARE MAYFAIR, LONDON X0 W1J6EQ UNITED KINGDOM 0 0 1 0 Common stock 2018-10-23 4 C 0 2279023 A 2279023 I See Footnote Common stock 2018-10-23 4 P 0 700000 10.00 A 2979023 I See Footnote Series B Preferred Stock 2018-10-23 4 C 0 4352775 0.00 D Common Stock 2279023 0 I See Footnote The Series B Preferred Stock converted into LogicBio Therapeutics, Inc. (the "Issuer") common stock effective upon closing of the Issuer's initial public offering. These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. Arix Bioscience, Plc by: /s/ James Rawlingson, Chief Financial Officer 2018-10-25 Arix Bioscience Holdings Limited, by: /s/ James Rawlingson, Authorized Officer 2018-10-25